Our top pick for
Beginners
Seneca Biopharma Inc is an other business based in the US. Seneca Biopharma shares (CUR) are listed on the NASDAQ and all prices are listed in US Dollars. Seneca Biopharma employs 5 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Seneca Biopharma
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CUR – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Seneca Biopharma stock price (NASDAQ: CUR)
Use our graph to track the performance of CUR stocks over time.Seneca Biopharma shares at a glance
Information last updated 2021-01-22.
| 52-week range | $0.00 - $0.00 |
|---|---|
| 50-day moving average | $0.00 |
| Wall St. target price | $26.00 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-7.83 |
Buy Seneca Biopharma shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.1 - 6 of 6
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Seneca Biopharma stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Seneca Biopharma financials
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | 0% |
| Return on equity TTM | 0% |
| Profit margin | 0% |
| Book value | $2.50 |
| Market capitalisation | $4 million |
TTM: trailing 12 months
Seneca Biopharma share dividends
We're not expecting Seneca Biopharma to pay a dividend over the next 12 months.
Seneca Biopharma overview
Seneca Biopharma, Inc. , a clinical stage biopharmaceutical company, focuses on the research and development of nervous system therapies based on its proprietary human neuronal stem cells and small molecule compounds. The company's stem cell based technology enables the isolation and expansion of human neural stem cells from various areas of the developing human brain and spinal cord enabling the generation of physiologically relevant human neurons of various types. Its lead product candidate is NSI-189, a chemical entity, which has been completed Phase II clinical trial for the treatment of major depressive disorder, as well as is in preclinical study for the treatment-refractory depression, Angelman Syndrome, Alzheimer's disease, ischemic stroke, diabetic neuropathy, irradiation-induced cognitive deficit, and long-term potentiation enhancement. The company also develops NSI-566, which has completed Phase II clinical trial for treating amyotrophic lateral sclerosis disease; Phase II clinical trial for the treatment of chronic ischemic stroke; and Phase I clinical trials for the treatment of chronic spinal cord injury, as well as is in preclinical study for the traumatic brain injury. In addition, it develops NSI-532, which is in preclinical study for treatment of Alzheimer's disease; and NSI-777 that is in preclinical study for treatment of human demyelinating diseases. The company was formerly known as Neuralstem, Inc.
Frequently asked questions
How many people work for Seneca Biopharma?Latest data suggests 5 work at Seneca Biopharma. When does the fiscal year end for Seneca Biopharma?
Seneca Biopharma's fiscal year ends in December. Where is Seneca Biopharma based?
Seneca Biopharma's address is: 20271 Goldenrod Lane, Suite 2024 20876,Germantown,USA What is Seneca Biopharma's ISIN number?
Seneca Biopharma's international securities identification number is: US81689B1035 What is Seneca Biopharma's CUSIP number?
Seneca Biopharma's Committee on Uniform Securities Identification Procedures number is: 64127R302
More guides on Finder
-
Alternatives to Webull
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
-
Best renewable energy stocks for 2022
Here are the best renewable energy stocks that should be on your radar to help you grow your green portfolio
-
Manganese stocks
Here are 6 manganese stocks that should be on your radar as EV batteries create new demand.
-
The best dividend stocks for 2022
Our list of 10 dividend stocks to watch in 2022.
-
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
-
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
-
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
-
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
-
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
-
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Ask an Expert